Mereo BioPharma MREO
NASDAQ MREO
$0.28 -0.01 (-1.98%)
At close: Oct 23, 2026 · 4:00 PM EDT

Mereo BioPharma (MREO) Selling, General & Administrative (2023 - 2026)

Updated

Mereo BioPharma (MREO) recorded Selling, General & Administrative of $5.22 million in Q2 2026, down 5.0% from $5.49 million a year earlier but up 29.9% from the prior quarter.

Analysis

Mereo BioPharma (MREO) Selling, General & Administrative (2023 - 2026) Analysis & Trends

On a TTM basis, Mereo BioPharma's Selling, General & Administrative came in at $19.48 million as of Jun 30, 2026, down 23.4% year-over-year; for FY2025, it was $23.01 million, down 13.0% from FY2024.

  • Annual Selling, General & Administrative has a three-year compound annual growth rate of -4.1% (FY2022 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $26.43 million in FY2024 (+43.5%), $18.42 million in FY2023 (-29.4%) and $26.11 million in FY2022.
  • Quarterly Selling, General & Administrative has ranged from $2.67 million in Q2 2023 to $7.87 million in Q2 2024 over the past five years.
  • On a year-over-year basis, Selling, General & Administrative has declined for five consecutive quarters, with an average decline of 0.8% over the last eight quarters.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 194.8% in Q2 2024, against a decline of 44.7% in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $4.02 million (Q1 2026), $4.2 million (Q4 2025) and $6.05 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 6.29 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 3.63 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 5.65 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 1.92 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 3.41 Bn
10 Mereo BioPharma 44.55 Mn -105.36 Mn - 5.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.22 Mn
Mar 31, 2026 4.02 Mn
Dec 31, 2025 4.20 Mn
Sep 30, 2025 6.05 Mn
Jun 30, 2025 5.49 Mn
Mar 31, 2025 7.27 Mn
Dec 31, 2024 6.45 Mn
Sep 30, 2024 6.20 Mn
Jun 30, 2024 7.87 Mn
Mar 31, 2024 5.91 Mn
Dec 31, 2023 3.60 Mn
Sep 30, 2023 5.71 Mn
Jun 30, 2023 2.67 Mn
Mar 31, 2023 6.45 Mn
API Access

Mereo BioPharma Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MREO&period=max&api_key=YOUR_API_KEY